Innovative Technology 4basebio's proprietary synthetic DNA and non-viral delivery system Hermes™ offers highly customizable solutions with rapid turnaround, making it attractive to biotech firms seeking advanced gene therapy and vaccine platforms.

Expanding Market Potential Operating in a growing sector with competitors like GenScript and Aldevron, 4basebio has opportunities to capture market share by emphasizing its safety profile, efficiency, and customization capabilities to potential clients in gene therapy and research.

Research and Development Focus With a focus on next-generation therapies, there is potential to partner with pharmaceutical companies, academic institutions, and biotech firms investing in gene editing, genome therapeutics, and vaccine development.

Strategic Collaborations Targeting collaborations with industry leaders and funding bodies in the UK and globally can accelerate growth, leverage product innovation, and expand the client base for bespoke DNA and delivery solutions.

Growth and Funding Opportunities Although current revenue is between 1M and 10M, exploring strategic investments, grants, and partnerships can enhance infrastructure, scale manufacturing, and increase market reach to support the company's expansion plans.